Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy

Table 1

Comparison of different baseline characteristics between HCM patients with and without complications following the insertion of an implantable cardioverter defibrillator.

Variables		With complications	Without complications	value
Gender	Male	7 (53.8%)	34 (58.6%)	0.75
	Female	6 (46.2%)	24 (41.4%)
DM positive history	Yes	3 (23.1%)	19 (32.8%)	0.74
	No	10 (76.9%)	39 (67.2%)
Hypertension positive history	Yes	9 (69.2%)	21 (36.2%)	0.03
	No	4 (30.8%)	37 (63.8%)
Antiarrhythmic drugs consumption	Yes	7 (53.8%)	22 (37.9%)	0.29
	No	6 (46.2%)	36 (62.1%)
Age, years		59.4 ± 16.2	61.7 ± 14.9	0.62

All data are expressed as the frequency and percentage for qualitative variables or the mean ± standard deviation for quantitative variables. Data analysis was performed using the chi-square test or Fisher’s exact test for qualitative variables and t-test for quantitative variables. DM, diabetes mellitus; HCM, hypertrophic cardiomyopathy.